Immunic Aktie
WKN: A2PHD4
ISIN: US4525EP1011
Land: USA
Branche: Sonstiges
Sektor: Sonstiges
Gratis: Die zehn beliebtesten US-Aktien im Check! Info...
0,8000 EUR -0,0300 EUR -3,61 %
22:59:50 L&S RT
Komplette Navigation anzeigen

News und Analysen

EQS-News: Immunic, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Issuer: Immunic AG / Key word(s): Quarter Results Immunic, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update 07.08.2025 / 12:30 CET/CEST The ...weiterlesen

24.06.25
EQS-News: Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis
05.06.25
EQS-News: Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Relapsing MS and Presents Additional Data Underlining Positive Outcome of Phase 2 CALLIPER Trial in Progressive M
02.06.25
EQS-News: Immunic to Participate in Investor, Scientific and Industry Conferences in June
02.05.25
EQS-News: Immunic to Participate in Scientific and Industry Conferences in May
30.04.25
EQS-News: Immunic Announces Vidofludimus Calcium Reduced Risk of Disability Worsening by 30% in Primary Progressive Multiple Sclerosis Patients from Phase 2 CALLIPER Trial
10.04.25
EQS-News: Immunic, Inc. Announces Closing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments
09.04.25
EQS-News: Immunic, Inc. Announces Pricing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments
01.04.25
EQS-News: Immunic, Inc. to Participate in Scientific and Industry Conferences in April
03.03.25
EQS-News: Immunic to Participate in Scientific and Investor Conferences in March
Seite: 1 | 2 | ►

Jetzt neu: